Dr. John Xavier Dantonio

DDS | Dentist



  
  10 Brentwood Dr, Cheektowaga
  New York, 14227-3208

  716-668-1626    Maps & Directions
Dr. John Xavier Dantonio is a Cheektowaga, New York based Dentist who is specialized in General Practice Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 10 Brentwood Dr, Cheektowaga. Patients can reach him at 716-668-1626.
Dr. John Xavier Dantonio is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. John Xavier Dantonio speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. John Xavier Dantonio
Specialization: Dentist
Gender:Male
Credentials: DDS
Accepts Medicare Assignment:May Accept
Practice Address:10 Brentwood Dr, Cheektowaga,
New York, 14227-3208
Phone:716-668-1626
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 7810294022
Enrollment ID: I20160401000493
NPI Number: 1275623696
NPI Enumeration Date: 14 Oct, 2006
NPI Last Update On: 08 Jul, 2007

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 13 Stone Hedge Dr,
Lancaster, New York
Zip: 14086-1431
Phone Number: 716-685-0635
Patients can reach Dr. John Xavier Dantonio at 10 Brentwood Dr, Cheektowaga, New York or can call to book an appointment on 716-668-1626. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.

Comments/ Reviews: